Replimune Group, Inc. (REPL) Insider Trading
Over the last 3 months, REPL insiders made 2 open-market buys and 5 sales, a net sale of -$1.0M (SEC Form 4). Over the last 6 months, 138 institutions increased and 101 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
2
Sells (3m)
5
Net (3m)
-$1.0M
Insiders buying
Insider trades by month Buys Sells
Nov
Dec
Apr
May
Jun
Aug
Context3-month price +69.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Hill Emily Luisaofficer: Chief Financial Officer | Sell | 9,256 | $14.28 |
| Aug 12, 2026 | Xynos Konstantinosofficer: Chief Medical Officer | Sell | 11,447 | $12.97 |
| Aug 12, 2026 | Patel Sushildirector, officer: Chief Executive Officer | Sell | 39,341 | $12.97 |
| Aug 12, 2026 | Hill Emily Luisaofficer: Chief Financial Officer | Sell | 11,448 | $12.97 |
| Aug 12, 2026 | Schwendenman Andrewofficer: Chief Accounting Officer | Sell | 7,632 | $12.97 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LPdirector, 10 percent owner: | Buy | 126,394 | $0.00 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LPdirector, 10 percent owner: | Buy | 2,609,946 | $0.00 |
| Jun 3, 2026 | Sarchi Christopherofficer: Chief Commercial Officer | Sell | 12,000 | $9.24 |
| May 20, 2026 | Xynos Konstantinosofficer: Chief Medical Officer | Sell | 14,023 | $5.08 |
| May 20, 2026 | Hill Emily Luisaofficer: Chief Financial Officer | Sell | 7,812 | $5.08 |
| May 20, 2026 | Schwendenman Andrewofficer: Chief Accounting Officer | Sell | 7,894 | $5.08 |
| May 20, 2026 | Astley-Sparke Philipdirector | Sell | 17,657 | $5.08 |
| May 20, 2026 | Patel Sushildirector, officer: Chief Executive Officer | Sell | 37,324 | $5.08 |
| May 20, 2026 | Sarchi Christopherofficer: Chief Commercial Officer | Sell | 8,626 | $5.08 |
| Apr 7, 2026 | Hill Emily Luisaofficer: Chief Financial Officer | Grant | 75,000 | $7.61 |
| Apr 7, 2026 | Astley-Sparke Philipdirector | Grant | 75,000 | $7.61 |
| Apr 7, 2026 | BAKER BROS. ADVISORS LPdirector, 10 percent owner: | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Schwendenman Andrewofficer: Chief Accounting Officer | Grant | 55,000 | $7.61 |
| Apr 7, 2026 | Xynos Konstantinosofficer: Chief Medical Officer | Grant | 75,000 | $7.61 |
| Apr 7, 2026 | Weinand Dieterdirector | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Balachandran Madhavandirector | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Pucci Paolodirector | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Xynos Konstantinosofficer: Chief Medical Officer | Grant | 50,000 | — |
| Apr 7, 2026 | Dhingra Kapildirector | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Oliger Christy J.director | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Astley-Sparke Philipdirector | Grant | 50,000 | — |
| Apr 7, 2026 | Peeples-Dyer Velekadirector | Grant | 44,500 | $7.61 |
| Apr 7, 2026 | Hill Emily Luisaofficer: Chief Financial Officer | Grant | 50,000 | — |
| Apr 7, 2026 | Patel Sushildirector, officer: Chief Executive Officer | Grant | 376,860 | $7.61 |
| Apr 7, 2026 | Sarchi Christopherofficer: Chief Commercial Officer | Grant | 75,000 | $7.61 |
Source: REPL SEC Form 4 filings, latest Aug 19, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their REPL positions over the last 6 months (SEC Form 13F).
Increased
138
New positions
120
Reduced
101
Sold out
56
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 11.0M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 11.0M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 9.0M | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 8.1M | May 15, 2026 |
| RTW INVESTMENTS, LP | Increased | 7.4M | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Increased | 7.4M | May 15, 2026 |
| Ridgeback Capital Investments L.P. | New Position | 7.3M | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 6.2M | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4.6M | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4.4M | Aug 7, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4.4M | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4.2M | May 15, 2026 |
| Boxer Capital Management, LLC | Increased | 4.0M | Aug 14, 2026 |
| Caption Management, LLC | Increased | 4.0M | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3.8M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.